Cytopoint (lokivetmab) is a monthly injectable monoclonal antibody that blocks interleukin-31 (IL-31), the molecule that transmits the itch signal. Unlike Apoquel, it does not suppress the immune system — making it the safer long-term option for infection-prone dogs. Like Apoquel, it manages symptoms without treating the root cause. Gut restoration, antifungal support, and dietary optimization are the complementary layers that address what Cytopoint cannot.
Cytopoint (lokivetmab) is the other major prescription option for canine allergic itch, alongside Apoquel. Where Apoquel is a daily pill, Cytopoint is a monthly injection administered by your veterinarian. Both target itch at a molecular level, but through completely different mechanisms — and the difference matters.
Since its launch in 2016, Cytopoint has become the preferred choice for many owners and veterinarians because of its favorable safety profile compared to daily immunosuppressive medication. But like any treatment that manages symptoms without addressing root causes, it has limitations that every owner should understand.
How Cytopoint Works
Cytopoint is a monoclonal antibody — a laboratory-produced protein designed to target and neutralize a specific molecule in the body. It targets interleukin-31 (IL-31), a cytokine (signaling protein) that plays a central role in transmitting the itch signal from inflamed skin to the brain.
The mechanism is narrow and targeted: Cytopoint binds to IL-31 and neutralizes it before it can activate itch receptors on sensory nerves. The itch signal is interrupted at the molecular level. The dog stops scratching — not because the inflammation is gone, but because the itch signal is no longer being transmitted.
Unlike Apoquel (which inhibits JAK enzymes involved in multiple immune pathways) and corticosteroids (which suppress the immune system broadly), Cytopoint targets only one molecule. It does not suppress the immune system's ability to fight infections, surveil for tumors, or regulate inflammation. Each injection lasts approximately 4 to 8 weeks.
Cytopoint vs. Apoquel: The Key Differences
| Factor | Cytopoint | Apoquel |
|---|---|---|
| Mechanism | Blocks IL-31 (single cytokine) | JAK1/JAK3 inhibitor (multiple immune pathways) |
| Immune impact | No immune suppression | Reduces immune surveillance — infections, tumors |
| Infection risk | Not increased | Increased (yeast, bacteria, parasites) |
| Speed of relief | 24–48 hours | 4 hours (faster) |
| Administration | Monthly vet injection | Daily tablet (owner-administered) |
| Age restriction | Any age (including under 12 months) | Dogs over 12 months only |
| Tumor risk | Not documented | FDA label warning for long-term use |
| Long-term safety | Cleaner profile (current data) | More data available (approved earlier) |
Apoquel for Dogs: What It Does, Side Effects, and Natural Alternatives →
Whether You Choose Cytopoint, Apoquel, or Neither
The Dog Wellness Quiz identifies the root causes behind your dog's itching and recommends targeted gut and immune support.
Take the Quiz →What Cytopoint Does Well
Targeted itch control without immunosuppression. The single biggest advantage. Your dog gets itch relief without the increased infection risk, tumor surveillance concerns, or gastrointestinal side effects associated with JAK inhibitors and corticosteroids.
Simplicity. One injection every 4 to 8 weeks eliminates daily medication compliance. No pills to hide in food, no missed doses, no remembering the evening tablet.
Safe for concurrent use with most other treatments. Because Cytopoint does not affect immune pathways broadly, it can be safely combined with antibiotics, antifungals, supplements, and other medications. This makes it compatible with a multi-layered approach that includes gut health and antifungal support.
Safe for dogs of all ages. Cytopoint can be used in dogs under 12 months of age, unlike Apoquel which is restricted to dogs over 12 months.
Limitations and Considerations
It does not treat the cause of itching. Like Apoquel, Cytopoint manages the itch symptom without addressing the allergic response, the secondary infections, or the immune dysregulation driving the condition. When the antibody wears off (typically at 4 to 6 weeks), the itch returns because nothing has changed underneath.
It does not address secondary infections. If your dog's itching is partly driven by yeast overgrowth or bacterial infection, Cytopoint will block the itch signal but leave the infection untouched. The dog may feel less uncomfortable, but the infection continues to damage the skin and worsen the underlying condition.
Variable duration of effect. Some dogs get 8 weeks of relief per injection. Others get only 3 to 4 weeks. There is no way to predict duration in advance. Dogs whose relief fades quickly face higher costs from more frequent injections.
It can mask underlying worsening. By blocking the itch signal, Cytopoint can create the impression that the condition is stable when the underlying inflammation and infection may actually be progressing. Monitor for non-itch signs: skin darkening or thickening, increasing odor, spreading ear discharge, and coat deterioration — even if the dog is not scratching.
Cost accumulates. At $50 to $150 or more per injection every 4 to 8 weeks, indefinitely, the lifetime cost is substantial. Root-cause interventions that extend the interval between injections meaningfully reduce this cost over time.
Because Cytopoint blocks the itch signal without resolving the underlying condition, owners should actively monitor for skin darkening, coat deterioration, ear discharge, and odor changes. These signs indicate the condition is progressing even when scratching is suppressed.
Is Your Dog's Yeast Infection Actually Allergies? How to Tell →
Complementary Approaches That Improve Cytopoint Outcomes
Cytopoint's narrow mechanism and clean safety profile make it the most compatible prescription option for combining with root-cause interventions. Unlike Apoquel, which suppresses the immune pathways you are trying to restore through gut health, Cytopoint leaves those pathways intact while managing the itch symptom.
This means you can use Cytopoint for immediate comfort while simultaneously working on three root-cause layers:
Gut Restoration
Daily multi-strain probiotic with prebiotic fiber to rebuild the immune regulation that modulates allergic reactivity. This addresses the upstream immune dysregulation that Cytopoint manages downstream.
Antifungal Support
If yeast is a component of the itching — check for odor, dark ear discharge, paw staining — caprylic acid and oregano oil address it directly. Cytopoint blocks the itch from the yeast, but it does not eliminate the yeast. Antifungal support does.
Dietary Optimization
Protein-first, moderate-carbohydrate diet with omega-3 supplementation. Reduces inflammatory dietary inputs and yeast fuel while providing anti-inflammatory fatty acids that complement Cytopoint's itch-blocking effect.
The Gut-Yeast Connection: Why Probiotics Alone Don't Fix Yeast Infections →
Why 80% of Dog Skin Problems Start in the Gut →
5 Natural Remedies for Dog Yeast Infections (What the Research Actually Says) →
- Cytopoint targets only IL-31 — the itch-signaling cytokine — without suppressing broader immune function. This is its primary advantage over Apoquel and corticosteroids.
- It does not increase infection risk, does not have tumor surveillance concerns, and can be used in dogs under 12 months.
- Like Apoquel, it manages the itch symptom without treating the underlying cause. When it wears off, itching returns.
- Because Cytopoint does not suppress the immune system, it is uniquely compatible with complementary root-cause interventions — gut restoration, antifungal support, and dietary optimization can run simultaneously without conflict.
- The strategic goal of the combined approach is to extend the interval between injections, reduce seasonal dependence, and in some cases eliminate the need for Cytopoint once root-cause protocols are fully established.
Frequently Asked Questions
Neither is universally better — they suit different situations. Cytopoint has a cleaner safety profile (no immunosuppression, no infection risk, no tumor concern) and is preferred for dogs who are infection-prone, under 12 months, or on long-term therapy. Apoquel provides faster onset (4 hours vs 24 to 48 hours) and allows dose adjustments that Cytopoint's fixed injection schedule cannot offer. For dogs who need both speed and long-term safety, some vets use Apoquel for acute flares and Cytopoint for maintenance.
Yes, and some veterinary dermatologists use both simultaneously for severe cases: Cytopoint for baseline itch control and Apoquel added during acute flares. However, the combination means your dog is receiving both a monoclonal antibody and an immunosuppressant, so the risk-benefit calculation should be discussed with a specialist.
This is a reported pattern in some dogs. The most likely explanation is that the underlying condition — allergic inflammation, secondary infection — is progressing over time. Each injection blocks the itch signal, but the worsening inflammation produces a stronger signal that overcomes the antibody's blocking capacity sooner. This is a strong indicator that root-cause interventions are needed alongside the injection. Addressing only the itch while the underlying condition worsens is a losing strategy.
Cytopoint has very few contraindications. The main caution is for dogs with known hypersensitivity to the antibody (rare, as it is a caninized monoclonal antibody designed to minimize immune rejection). There are no age restrictions, no liver or kidney monitoring requirements, and no drug interactions. It is one of the safest prescription options available for canine allergic itch, which is why many veterinary dermatologists have made it their first-line recommendation.
Complement Cytopoint With Root-Cause Support
YeastGuard + GutGuard address the yeast and gut health that Cytopoint's itch relief cannot reach. A complementary approach for complete results.
Shop the Welcome Bundle →
